FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:882-883 March 20, 1997 Number 12 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

Edited by Harold Y. Vanderpool. 531 pp. Frederick, Md., University Publishing Group, 1996. $59. ISBN 1-55572-036-6.

We stand at a pivotal moment in the history of human experimentation. Long-standing suspicions about research are fading, along with an unconditional commitment to informed consent. The distinction between investigation and therapy is blurring; fears about using subjects as guinea pigs are being superseded by a belief that investigational drugs deliver miracle cures. These attitudes originated with AIDS and have spread to almost all diseases with no known cure, including Alzheimer's disease and cancer. In a manner consistent with this orientation, the Food and Drug Administration's drug-approval procedures have been streamlined, there is a new emphasis on enrolling women in . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.